Island Pharmaceuticals Ltd (AU:ILA) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Island Pharmaceuticals Ltd recently held its Annual General Meeting, updating stakeholders on proxy vote corrections for certain resolutions. The company, known for its work in repurposing antiviral drugs, is advancing its lead asset, ISLA-101, aimed at combating dengue fever and other mosquito-borne diseases. Successful FDA approval could potentially provide Island with a Priority Review Voucher, expediting future drug approvals.
For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.